Senhwa Biosciences, Inc. (TPEx: 6492), a drug development company focusing on first-in-class therapeutics for oncology, …
![](https://i0.wp.com/globalpharmalive.com/wp-content/uploads/2023/11/pexels-photo-7089401.webp?resize=760%2C427&ssl=1)
![](https://i0.wp.com/globalpharmalive.com/wp-content/uploads/2023/11/pexels-photo-7089401.webp?resize=760%2C427&ssl=1)
Pharma News From Around The World
Pharma News From Around The World
Pharma News From Around The World
Senhwa Biosciences, Inc. (TPEx: 6492), a drug development company focusing on first-in-class therapeutics for oncology, …